Publication

Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH

International Journal of Molecular Sciences 22:6332, 2021

Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS

Share this page

Resource Library

Related resources

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Preclinical drug discovery in NASH – Narrowing the translational gap

Development of hepatocellular carcinoma in the extended GAN diet-induced obese mouse model of NASH with advanced fibrosis

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650